trending Market Intelligence /marketintelligence/en/news-insights/trending/Gtyby06RjpR79-5ou9GbAQ2 content esgSubNav
In This List

PhotoMedex to appeal Nasdaq delisting decision

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise

Blog

Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises


PhotoMedex to appeal Nasdaq delisting decision

PhotoMedex Inc. said it would appeal a Nasdaq decision to delist its shares from the stock exchange.

The company has until 4 p.m. ET on May 30 to appeal the decision, which would stay the delisting until after the appeal is heard. Otherwise, the company's securities will be suspended at the opening of business June 1.

While the company met the stock exchange's continued listing requirements, it failed to submit an initial listing application after completing an agreement with First Capital Real Estate Trust Inc.

As a result, the company's stock again fell out of compliance and Nasdaq determined to delist PhotoMedex's securities — a decision the company will now appeal.